Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -33.86% is 56% above its 5-year average of -77.12%, near the high end of its 5-year range (-166.02%–-27.83%).
2.79% below its 12-month average of -32.94%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -28.98%.
OPERATING MARGIN
-33.86%
OPERATING MARGIN AVG TTM
-32.94%
OPERATING MARGIN AVG 3Y
-46.33%
OPERATING MARGIN AVG 5Y
-77.12%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.79%
CURRENT VS 3Y AVG
+26.91%
CURRENT VS 5Y AVG
+56.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 784 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
PROCEPT BioRobotics Corporation
Market Cap
$991.20M
Operating Margin
-33.86%
TTM Avg
-32.94%
3Y Avg
-46.33%
5Y Avg
-77.12%
Market Cap
$983.38M
Operating Margin
2.47%
TTM Avg
-2.95%
3Y Avg
4.03%
5Y Avg
7.25%
Market Cap
$979.81M
Operating Margin
-130.20%
TTM Avg
-311.82%
3Y Avg
-583.08%
5Y Avg
-487.88%
Market Cap
$979.53M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.00B
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$966.65M
Operating Margin
-1149.52%
TTM Avg
-2324.93%
3Y Avg
-1162.47%
5Y Avg
-1162.47%
Market Cap
$1.02B
Operating Margin
1.38%
TTM Avg
4.21%
3Y Avg
3.61%
5Y Avg
3.61%
Market Cap
$1.03B
Operating Margin
-8.99%
TTM Avg
-4.92%
3Y Avg
-23.48%
5Y Avg
-24.49%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation (PRCT) | $991.20M | -33.86% | -32.94% | -46.33% | -77.12% |
| Pacira BioSciences, Inc. (PCRX)vs › | $983.38M | 2.47% | -2.95% | 4.03% | 7.25% |
| MeiraGTx Holdings plc (MGTX)vs › | $979.81M | -130.20% | -311.82% | -583.08% | -487.88% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $966.65M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.38% | 4.21% | 3.61% | 3.61% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | -8.99% | -4.92% | -23.48% | -24.49% |
| Savara Inc. (SVRA)vs › | $952.91M | 0.00% | 0.00% | 0.00% | -3197.15% |
| Immatics N.V. (IMTX)vs › | $1.03B | -377.11% | -200.94% | -143.24% | -174.04% |
Gross Margin
63.7%
Operating Margin
-33.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -28.98% |
| 2026-03-31 | -39.22% |
| 2025-12-31 | -40.64% |
| 2025-09-30 | -27.83% |
| 2025-06-30 | -28.02% |
| 2025-03-31 | -39.67% |
| 2024-12-31 | -28.89% |
| 2024-09-30 | -38.42% |
| 2024-06-30 | -50.28% |
| 2024-03-31 | -62.08% |
| 2023-12-31 | -67.82% |
| 2023-09-30 | -72.96% |
| 2023-06-30 | -77.41% |
| 2023-03-31 | -116.28% |
| 2022-12-31 | -105.31% |
| 2022-09-30 | -108.63% |
| 2022-06-30 | -107.09% |
| 2022-03-31 | -110.61% |
| 2021-12-31 | -166.02% |
| 2021-09-30 | -147.63% |
| 2021-06-30 | -155.64% |
| 2021-03-31 | -157.73% |
| 2020-12-31 | -410.03% |
| 2020-09-30 | -521.03% |
| 2020-06-30 | -988.53% |
| 2020-03-31 | -988.53% |
